TPEX/4162 (TPEX/4162)

Taipei Exchange: TPEX/4162 · TWD

NT$56.1

+0.20 (+0.4%)· Recorded snapshot

Market cap	8.1B
Revenue (ttm)	1B
Net income (ttm)	538.8M
EPS (ttm)	NT$3.75
Shares out	143.7M
P/E (trailing)	15.0x
Dividend	NT$2.00 (3.56%)
Volume	149,603
Beta	0.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1B
Net income (ttm): 538.8M
EPS (ttm): NT$3.75
P/E (trailing): 15.0x
Market cap: 8.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E15

P25 n/aP50 n/aP75 n/a

ROE11.3

P25 n/aP50 n/aP75 n/a

ROIC36

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TPEX/4162 indicators

Market & fundamental data

Available fields

262

Groups with data

Currency

TWD

Showing 262 of 262 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	TWD
Country	Taiwan
Country code	TW
Earnings date	2026-11-06
Employees	45
Employees change	1
Employees growth	2.27%
Enterprise value	TWD 3B
Exchange	Taipei Exchange
Financial currency	TWD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2002
Industry	Biotechnology
Is primary listing	Yes
ISIN number	TW0004162003
Last earnings date	2025-11-12
Last refreshed	2026-10-28
Last stock split date	2017-07-26
Last stock split type	Forward
Market cap	TWD 8.1B
Next earnings date	2026-11-06
Price	TWD 56.10
Price currency	TWD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	tpex/4162
Website	https://www.pharmaengine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	71.72x
Average P/E ratio (3Y)	26.12x
Average P/E ratio (5Y)	30.51x
Earnings yield	6.68%
EV/Earnings	5.62x
EV/EBIT	6.24x
EV/EBITDA	6.1x
EV/FCF	5.6x
EV/Sales	2.95x
FCF / EV yield	17.85%
FCF yield	6.7%
Graham number	53.69275
Graham upside	-4.29%
Industry forward P/E	174.77x
Lynch fair value	TWD 18.75
Lynch upside	-66.58%
P/(FCF - SBC) ratio	14.92x
P/(OCF - SBC) ratio	14.91x
P/B ratio	1.64x
P/E ratio	14.96x
P/FCF ratio	14.92x
P/OCF ratio	14.91x
P/S ratio	7.86x
Price / tangible book value	1.64x
Price/EBITDA ratio	16.56x
Sector forward P/E	28.08x
Sector P/E	83.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	47.32%
EBITDA margin	47.49%
Effective tax rate	16.66%
FCF margin	52.71%
Gross margin	93.87%
Operating margin	47.32%
Pretax margin	63.07%
Profit margin	52.56%
Profit per employee	TWD 12M
Profitable quarters	26
Profitable years	12
Revenue per employee	TWD 22.8M
ROA	5.44%
ROA (5Y)	9.06%
ROCE	9.81%
ROE	11.26%
ROE (5Y)	14.26%
ROIC	36.04%
SBC / revenue	0%
Tax / revenue	10.51%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.9%
EPS growth (Q)	675%
EPS growth (QoQ)	-2.11%
EPS growth 10Y	12.67%
EPS growth 3Y	21.9%
EPS growth 5Y	-6.93%
EPS growth quarters	2
EPS growth years	0
FCF growth	-69.02%
FCF growth (QoQ)	-62.17%
FCF growth 3Y	24%
FCF growth 5Y	-8.27%
Gross profit growth	-60.45%
Gross profit growth (Q)	28.55%
Gross profit growth 3Y	17.33%
Gross profit growth 5Y	-2.95%
Net income growth	-66.96%
Net income growth (Q)	653.64%
Net income growth (QoQ)	-2.32%
Net income growth 3Y	21.88%
Net income growth 5Y	-7.19%
Net income growth quarters	2
Net income growth years	0
OCF growth	-69%
OCF growth (QoQ)	-62.09%
OCF growth 10Y	0.2%
OCF growth 3Y	23.58%
OCF growth 5Y	-8.26%
Operating income growth	-76.09%
Operating income growth (Q)	18.9%
Operating income growth 3Y	33.61%
Operating income growth 5Y	-11.05%
Revenue growth	-58.69%
Revenue growth (Q)	31.11%
Revenue growth (QoQ)	7.6%
Revenue growth 10Y	11.99%
Revenue growth 3Y	16.53%
Revenue growth 5Y	-2.38%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	TWD -339,000
Depreciation and amortization	TWD 1.7M
EBIT	TWD 485.1M
EBITDA	TWD 486.8M
EPS	TWD 3.75
FCF per share	TWD 3.76
Financing cash flow	TWD -870.6M
Free cash flow	TWD 540.3M
Free cash flow minus SBC	TWD 540.3M
Gross profit	TWD 962.2M
Income taxes	TWD 107.7M
Investing cash flow	TWD -1.3B
Net borrowing	TWD -8.7M
Net cash flow	TWD -1.6B
Net income	TWD 538.8M
Operating cash flow minus SBC	TWD 540.6M
Operating income	TWD 485.1M
Revenue	TWD 1B
Stock-based compensation	TWD 48,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	13.18
Book value per share	TWD 34.17
Debt / EBITDA	0.08
Debt / equity	0.01
Debt / FCF	0.07
Interest coverage	979.95
Long-term assets	TWD 56.1M
Long-term liabilities	TWD 33.4M
Net cash (debt)	TWD 5B
Net cash / market cap	62.45%
Net cash growth	-6.73%
Net debt / EBITDA	-10.34
Net debt / equity	-1.03
Net debt / FCF	-9.32
Piotroski F-Score	5
Property, plant and equipment	TWD 39.7M
Shareholders' equity	TWD 4.9B
Tangible book value	TWD 4.9B
Tangible book value per share	TWD 34.17
Total assets	TWD 5.4B
Total cash	TWD 5.1B
Total debt	TWD 37.8M
Total liabilities	TWD 512.3M
WACC	4.85%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.18
Current assets	TWD 5.4B
Current liabilities	TWD 478.9M
Current ratio	11.2
Inventory turnover	1.71
Net working capital	TWD -176M
Quick ratio	11.11
Working capital	TWD 4.9B
Working capital turnover	0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.05%
Dividend growth	-66.67%
Dividend growth (10Y)	1.84%
Dividend growth (3Y)	0%
Dividend growth (5Y)	-4.63%
Dividend growth years	1
Dividend payment date	2026-09-04
Dividend payment years	12
Dividend payout frequency	Annual
Dividend per share	TWD 2.00
Dividend yield	3.57%
Ex-dividend date	2026-08-17
FCF payout ratio	53.18%
Last dividend	TWD 2.00
Payout ratio	159.97%
Shareholder yield	3.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-69.12%
10Y return CAGR	-8.59%
10Y total return	-59.26%
150-day SMA	TWD 58.39
15Y price change	42.97%
15Y return CAGR	4.55%
15Y total return	94.84%
1D price change	0.36%
1M price change	1.08%
1M total return	1.08%
1W price change	-0.18%
1W total return	-0.18%
1Y price change	-18.22%
1Y return CAGR	-15.51%
1Y total return	-15.5%
20-day SMA	TWD 56.13
200-day SMA	TWD 60.38
3M price change	-14.74%
3M total return	-11.9%
3Y price change	-52.46%
3Y return CAGR	-18.48%
3Y total return	-45.83%
50-day SMA	TWD 57.09
50-day SMA vs 200-day SMA	50under200
52-week high	TWD 74.40
52-week high date	2025-12-08
52-week low	TWD 53.00
52-week low date	2026-05-28
5Y price change	-2.77%
5Y return CAGR	3.22%
5Y total return	17.19%
6M price change	4.28%
6M total return	7.75%
All-time high	TWD 246.55
All-time high date	2014-05-28
All-time low	TWD 33.10
All-time low date	2020-03-23
Average true range (ATR)	TWD 0.97
Average volume	197.5K
Beta (1Y)	0.2
Beta (2Y)	0.33
Beta (5Y)	0.11
Change from 52-week high	-24.6%
Change from 52-week low	5.85%
Change from all-time high	-77.25%
Change from all-time low	69.49%
Change from open	0.18%
Day's gap	0.18%
Dollar volume	TWD 8.4M
High price	TWD 56.30
Low price	TWD 55.70
Monthly RSI	36.63
Open price	TWD 56.00
Position in 52-week range	66.67%
Previous close	TWD 55.90
Price vs 150-day SMA	-3.93%
Price vs 20-day SMA	-0.05%
Price vs 200-day SMA	-7.09%
Price vs 50-day SMA	-1.74%
Relative volume	0.73
RSI	46.35
Sharpe ratio	-0.81
Sharpe ratio (3Y)	-0.19
Sharpe ratio (5Y)	0.17
Sortino ratio	-0.94
Sortino ratio (3Y)	-0.11
Sortino ratio (5Y)	0.41
Volume	149.6K
Weekly RSI	42.44
YTD price change	-20.31%
YTD total return	-17.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93.5M
Shares change (QoQ)	-0.09%
Shares change (YoY)	-0.05%
Shares held by insiders	1.23%
Shares held by institutions	5.79%
Shares outstanding	143.7M

Deeper analysis on TPEX/4162

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TPEX/4162 report

Is a complete TPEX/4162 research report available?

No complete published report is available for tpex/4162 (TPEX/4162) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/4162 (TPEX/4162)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/4162

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/4162 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TPEX/4162

Frequently asked questions